Rootsaert Rodney Gerard 4

What Happened Rodney Rootsaert, Secretary of VolitionRx Ltd (VNRX), was granted 119,000 restricted stock units (RSUs) on February 26, 2026 (transaction code A). The Form 4 reports an acquisition at $0.00 (i.e., no cash paid). These RSUs are earned in twelve approximately equal monthly installments beginning March 1, 2026, and those earned RSUs remain subject to additional time-based vesting in a single installment on February 26, 2027. This is an award/grant (not an open-market purchase or sale).

Key Details

• Transaction date: 2026-02-26; Transaction type: Award/Grant (A); Price reported: $0.00.
• Shares/units awarded: 119,000 RSUs (will convert to common shares upon earning and vesting).
• Shares owned after transaction: The filing does not state a post-transaction beneficial ownership total; the award currently exists as RSUs that convert to shares after earning and vesting.
• Footnote: RSUs were awarded in lieu of cash compensation. RSUs vest in monthly earning installments (starting 3/1/2026) and then further vest in full on 2/26/2027, subject to continued service.
• Ownership/control note: The filing states shares of common stock are held directly by Concord International, Inc.; Rootsaert is a controlling director of Concord and shares voting and dispositive control over those shares.
• Filing timeliness: Report filed 2026-02-27 for a 2026-02-26 transaction (no late filing indicated).

Context This was a compensation award (RSUs) rather than a purchase or sale. RSUs do not represent immediately tradable shares — they convert to common stock only as they are earned and vest per the schedule noted, and are conditioned on continued service. The grant was made in lieu of cash compensation; the Form 4 reports no cash paid at grant.